COMMUNIQUÉS West-GlobeNewswire

FDA Approves Labeled Strength Update of TWIRLA® (levonorgestrel/ethinyl estradiol) Birth Control Patch
19/06/2026
FLORHAM PARK, N.J., June 19, 2026 (GLOBE NEWSWIRE) -- Exeltis USA, Inc. (Exeltis), a global pharmaceutical company specializing in women’s health, announced that the U.S. Food and Drug Administration (FDA) has approved [...]
Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam
19/06/2026
Panel to Address Litecoin's Institutional Evolution, Marking the First Time a Digital Asset Treasury Company Has Taken the Stage at the Litecoin Foundation's Annual Summit SAN DIEGO, June 19, 2026 (GLOBE NEWSWIRE) -- [...]
Communiqué de presse : Sarclisa de Sanofi en formulation sous-cutanée approuvé au Japon pour les patients atteints de myélome multiple
19/06/2026
Sarclisa de Sanofi en formulation sous-cutanée approuvé au Japon pour les patients atteints de myélome multiple Approbation basée sur plusieurs études, y compris l’étude pivot de phase 3 IRAKLIA qui a démontré une [...]
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0650 Per Share
19/06/2026
SAN JUAN CAPISTRANO, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
Communiqué de presse : Sanofi et HEC Paris lancent la « Sanofi MBA Life Sciences Scholarship » pour accompagner les futurs leaders de la santé
19/06/2026
Sanofi et HEC Paris lancent la « Sanofi MBA Life Sciences Scholarship » pour accompagner les futurs leaders de la santé Paris, le 19 juin 2026 — Sanofi et HEC Paris annoncent le lancement de la “ Sanofi MBA Life [...]
Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026
19/06/2026
Global CRO expands its operational footprint into Singapore and Malaysia, strengthens China presence, and grows India operations - creating a powerhouse in the Asia Pacific region ADELAIDE, Australia, June 19, 2026 ( [...]
Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026
19/06/2026
Global CRO expands its operational footprint into Singapore and Malaysia, strengthens China presence, and grows India operations - creating a powerhouse in the Asia Pacific region ADELAIDE, Australia, June 19, 2026 ( [...]
Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
19/06/2026
Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Approval based on multiple studies, including the pivotal IRAKLIA phase 3 study which demonstrated non-inferior efficacy [...]
Professor Mohamed Shamji Assumes Presidency of EAACI as Congress 2026 Concludes in Istanbul
19/06/2026
New leadership begins as the global allergy community advances the Vision Zero ambition of a future free from allergy and asthma burden ISTANBUL, June 19, 2026 (GLOBE NEWSWIRE) -- The European Academy of Allergy and [...]
New European initiative to accelerate drug discovery for cardiometabolic diseases
19/06/2026
COPENHAGEN, Denmark, June 19, 2026 (GLOBE NEWSWIRE) -- The Novo Nordisk Foundation is funding a new pan-European initiative to accelerate drug discovery and the development of next generation therapeutics for [...]
Kither Biotech successfully completes Phase 1 clinical trial of KIT2014, a novel inhaled peptide therapy for respiratory diseases
19/06/2026
First-in-human Phase 1 study in 56 healthy participants demonstrated KIT2014’s safety and tolerability KIT2014 is being developed as an inhalation therapy for respiratory diseases including chronic obstructive pulmonary [...]
Arletta Pharma Solutions Appoints Steve van Os, MD, as Chief Medical Officer
19/06/2026
www.arlettapharmasolutions.com Seasoned biotech executive brings more than two decades of global clinical development, medical affairs and regulatory leadership across oncology, women’s health and endocrinology [...]
Nutraville Expands Product Line with Pineal Guardian X, a Natural Brain Wellness Support
19/06/2026
Columbus, OH, June 19, 2026 (GLOBE NEWSWIRE) -- Nutraville, a natural wellness supplement brand, has launched Pineal Guardian X, a new dietary supplement designed to support brain wellness, mental clarity, daily focus, [...]
Desert Hope Treatment Center Launches First Responder Lifeline Program, Offering Confidential Care for Frontline Heroes
19/06/2026
LAS VEGAS, June 18, 2026 (GLOBE NEWSWIRE) -- Desert Hope Treatment Center, a leading addiction treatment center in Las Vegas, has introduced its First Responder Lifeline Program, designed specifically for law [...]
Hi*Ball Energy fait son entrée au Royaume-Uni et redéfinit les codes de la boisson énergisante
18/06/2026
Faites le plein d’énergie autrement avec Hi*Ball Sparkling Energy Water, une boisson pétillante énergisante qui se veut audacieuse et sans compromis, composée de caféine naturelle et d’ingrédients fonctionnels, sans [...]
Teva Releases Q2 2026 Aide Memoire
18/06/2026
TEL AVIV, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q2 2026 Aide Memoire is available on the “Investors” page on its website. Q2 2026 [...]
Vireo Growth Inc. Completes Acquisition of Equity Interest in Maryland Dispensaries
18/06/2026
MINNEAPOLIS, June 18, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOD) (“Vireo” or the “Company”), today announced the closing of its previously announced acquisition to acquire an indirect 49% [...]
Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome
18/06/2026
NDA submission supported by positive Phase 3 data recently published in JAMA Neurology. Ecopipam is a first-in-class selective dopamine D1 receptor antagonist with a novel mechanism of action and has received FDA Orphan [...]
Teva to Host Conference Call to Discuss Second Quarter 2026 Financial Results on July 29, 2026 at 8 a.m. ET
18/06/2026
TEL AVIV, Israel and PARSIPPANY, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2026 financial [...]

Pages